Literature DB >> 1457589

Some storage characteristics of buffy coats used for preparation of platelet concentrates.

P Järemo1, A Shaba, J Kutti.   

Abstract

The present study examined biochemical storage lesions in 58 buffy coats (BCs) intended as the raw material for platelet concentrates. The work was conducted in three series; the aims were to investigate: (a) the storage quality of BCs obtained from the routine production (series I), (b) whether improvement in platelet quality could be achieved by continuous agitation during storage (series II), and (c) whether macroscopic aggregate formation indicates platelet damage (series III). Series I and II consisted of 20 BCs each. Series III compared ten BCs with visible clumping with eight BCs not demonstrating macroscopic aggregates. In series I and II platelet counts and platelet factor 4 (PF4) release were determined after 1, 3, 5, and 24 h; lactate dehydrogenase (LDH) extracellular activity was measured after 1 and 24 h. In addition, in series I elastase concentrations were analyzed after 3, 5, and 24 h. Finally, in series III extracellular beta-thromboglobulin (beta-TG) levels were determined after 18-24 h. Low platelet counts, most likely reflecting the presence of aggregate formation, were found in 20% of the BCs (series I); in this series a total of 25% demonstrated increasing platelet counts, together with elevated PF4 and elastase, over the study period. Significant biochemical storage lesions were found after 5 and 24 h of storage. The study also demonstrated that continuous agitation during storage does not improve platelet quality (series II) and that BCs demonstrating visible clumping (series III) had augmented levels of extracellular beta-TG (p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457589     DOI: 10.1007/bf01836072

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  12 in total

1.  Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies.

Authors:  L Eriksson; C F Högman
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

2.  Correlation of aggregometry responses to changes in light transmission through platelet packs.

Authors:  P Järemo; C Sollen; B Edlund; O Berseus
Journal:  Thromb Res       Date:  1991-05-01       Impact factor: 3.944

3.  Effect of white cells on platelets during storage.

Authors:  E M Sloand; H G Klein
Journal:  Transfusion       Date:  1990-05       Impact factor: 3.157

Review 4.  Platelet activating factor: a biologically active phosphoglyceride.

Authors:  D J Hanahan
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

5.  The bottom and top system: a new technique for blood component preparation and storage.

Authors:  C F Högman; L Eriksson; K Hedlund; J Wallvik
Journal:  Vox Sang       Date:  1988       Impact factor: 2.144

6.  Recommended methods for the determination of four enzymes in blood.

Authors: 
Journal:  Scand J Clin Lab Invest       Date:  1974-06       Impact factor: 1.713

7.  Platelet concentrates stored in plasma for 72 hours at 22 degrees C prepared from buffycoats of citrate-phosphate-dextrose blood collected in a quadruple-bag saline-adenine-glucose-mannitol system.

Authors:  R N Pietersz; J A Loos; H W Reesink
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

8.  "PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor.

Authors:  S Neumann; G Gunzer; N Hennrich; H Lang
Journal:  J Clin Chem Clin Biochem       Date:  1984-10

9.  Measurement of platelet activation by fluorescence-activated flow cytometry.

Authors:  L Corash
Journal:  Blood Cells       Date:  1990

10.  Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins.

Authors:  M S Brower; R I Levin; K Garry
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more
  1 in total

1.  Platelets, gender and acute cerebral infarction.

Authors:  Petter Järemo; Marie Eriksson-Franzen; Micha Milovanovic
Journal:  J Transl Med       Date:  2015-08-16       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.